Richard A. Larson to Proton Pump Inhibitors
This is a "connection" page, showing publications Richard A. Larson has written about Proton Pump Inhibitors.
Connection Strength
0.545
-
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia. Cancer Chemother Pharmacol. 2012 Aug; 70(2):345-50.
Score: 0.404
-
PepsiĀ® or CokeĀ®? Influence of acid on dasatinib absorption. J Oncol Pharm Pract. 2018 Mar; 24(2):156-158.
Score: 0.141